FDA Inspection 1098899 — Aerolase Corp.

Aerolase Corp. — FEI 3004374705

The FDA completed an inspection of Aerolase Corp. on August 8, 2019 in Tarrytown, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 8, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Radiation Control and Health Safety Act
Location
Tarrytown, NY (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
515021 CFR 1040.10(f)(3)Remote interlock connector
519721 CFR 1040.10(h)(1)(i)User information, adequate instructions
63021 CFR 803.17Lack of Written MDR Procedures